Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas G Altman

Showing results (41-50 of 544) with videos related to

Pageof 55
Sort By:
BMJ (Clinical Research Ed.)|July 20, 2004
Diagnostic tests 4: likelihood ratiosJonathan J Deeks, Douglas G Altman
BMJ (Clinical Research Ed.)|April 9, 2005
Treatment allocation by minimisationDouglas G Altman, J Martin Bland
BMJ (Clinical Research Ed.)|February 27, 2007
Missing dataDouglas G Altman, J Martin Bland
Chest|October 10, 2008
Reporting guidelines: looking back from the futureErik von Elm, Douglas G Altman
Journal of Biopharmaceutical Statistics|July 7, 2007
Agreement between methods of measurement with multiple observations per individualJ Martin Bland, Douglas G Altman
BMJ (Clinical Research Ed.)|February 24, 2018
Population attributable fractionMohammad Ali Mansournia, Douglas G Altman
Heart (British Cardiac Society)|June 13, 2012
Predicting the adverse risk of statin treatment: an independent and external validation of Qstatin risk scores in the UKGary S Collins, Douglas G Altman
The American Journal of Clinical Nutrition|September 11, 2015
Best (but oft forgotten) practices: testing for treatment effects in randomized trials by separate analyses of changes from baseline in each group is a misleading approachJ Martin Bland, Douglas G Altman
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|January 26, 2006
[Randomization and comparison of final quality in clinical studies]Douglas G Altman, Caroline J Doré
Clinical Chemistry|June 8, 2017
Assessing Agreement between Methods of MeasurementDouglas G Altman, J Martin Bland
Pageof 55

Showing results (41-50 of 544) with videos related to

Sort By:
Pageof 55
BMJ (Clinical Research Ed.)|July 20, 2004
Diagnostic tests 4: likelihood ratiosJonathan J Deeks, Douglas G Altman
BMJ (Clinical Research Ed.)|April 9, 2005
Treatment allocation by minimisationDouglas G Altman, J Martin Bland
BMJ (Clinical Research Ed.)|February 27, 2007
Missing dataDouglas G Altman, J Martin Bland
Chest|October 10, 2008
Reporting guidelines: looking back from the futureErik von Elm, Douglas G Altman
Journal of Biopharmaceutical Statistics|July 7, 2007
Agreement between methods of measurement with multiple observations per individualJ Martin Bland, Douglas G Altman
BMJ (Clinical Research Ed.)|February 24, 2018
Population attributable fractionMohammad Ali Mansournia, Douglas G Altman
Heart (British Cardiac Society)|June 13, 2012
Predicting the adverse risk of statin treatment: an independent and external validation of Qstatin risk scores in the UKGary S Collins, Douglas G Altman
The American Journal of Clinical Nutrition|September 11, 2015
Best (but oft forgotten) practices: testing for treatment effects in randomized trials by separate analyses of changes from baseline in each group is a misleading approachJ Martin Bland, Douglas G Altman
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|January 26, 2006
[Randomization and comparison of final quality in clinical studies]Douglas G Altman, Caroline J Doré
Clinical Chemistry|June 8, 2017
Assessing Agreement between Methods of MeasurementDouglas G Altman, J Martin Bland
Pageof 55